Combined Fluoxetine and Metformin Treatment Potentiates Antidepressant Efficacy Increasing IGF2 Expression in the Dorsal Hippocampus
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
An increasing number of studies show that selective serotonin reuptake inhibitors (SSRIs) exert their therapeutic action, at least in part, by amplifying the influence of the living environment on mood. As a consequence, when administered in a favorable environment, SSRIs lead to a reduction of symptoms, but in stressful conditions, they show limited efficacy. Therefore, novel therapeutic approaches able to neutralize the influence of the stressful environment on treatment are needed. The aim of our study was to test whether, in a mouse model of depression, the combined administration of SSRI fluoxetine and metformin, a drug able to improve the metabolic profile, counteracts the limited efficacy of fluoxetine alone when administered in stressful conditions. Indeed, metabolic alterations are associated to both the onset of major depression and the antidepressant efficacy. To this goal, adult C57BL/6 male mice were exposed to stress for 6 weeks; the first two weeks was aimed at generating a mouse model of depression. During the remaining 4 weeks, mice received one of the following treatments: vehicle, fluoxetine, metformin, or a combination of fluoxetine and metformin. We measured liking- and wanting-type anhedonia as behavioral phenotypes of depression and assessed the expression levels of selected genes involved in major depressive disorder and antidepressant response in the dorsal and ventral hippocampus, which are differently involved in the depressive symptomatology. The combined treatment was more effective than fluoxetine alone in ameliorating the depressive phenotype after one week of treatment. This was associated to an increase in IGF2 mRNA expression and enhanced long-term potentiation, specifically in the dorsal hippocampus, at the end of treatment. Overall, the present results show that, when administered in stressful conditions, the combined fluoxetine and metformin treatment may represent a more effective approach than fluoxetine alone in a short term. Finally, our findings highlight the relevance of polypharmacological strategy as effective interventions to increase the efficacy of the antidepressant drugs currently available.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879 · cited 1×
“However, the efficacy of SSRIs is variable and incomplete: 60–70% of patients do not experience remission and 30– 40% do not show a significant response [2].”
Are the Dorsal and Ventral Hippocampus Functionally Distinct Structures?
Fanselow, M. S., & Dong, H.-W. (2010) · Neuron · doi:10.1016/j.neuron.2009.11.031 · Cited by 3,358 · cited 1×
“Despite that the classic view on anatomical segregation of the hippocampal function considers the dorsal part to be involved in learning and memory while the ventral part in emotional and stress responses [48, 49], an increasing number of studies are challenging this dichotomy view [50, 51].”
Functional organization of the hippocampal longitudinal axis
Strange, B. A., Witter, M. P., Lein, E. S., & Moser, E. I. (2014) · Nature reviews. Neuroscience · doi:10.1038/nrn3785 · Cited by 1,738 · cited 1×
“Despite that the classic view on anatomical segregation of the hippocampal function considers the dorsal part to be involved in learning and memory while the ventral part in emotional and stress responses [48, 49], an increasing number of studies are challenging this dichotomy view [50, 51].”
Regional dissociations within the hippocampus-memory and anxiety
Bannerman, D. M., Rawlins, J. N. P., McHugh, S. B., Deacon, R. M. J., Yee, B. K., Bast, T., Zhang, W.-N., Pothuizen, H. H. J., & Feldon, J. (2004) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2004.03.004 · Cited by 1,462
Conner, J. M., Lauterborn, J. C., Yan, Q., Gall, C. M., & Varon, S. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-07-02295.1997 · Cited by 1,097 · cited 1×
“BDNF is a neurotrophic factor particularly abundant in hippocampal neurons [66] that has been indicated as a key player in the pathophysiology of MDD.”
Depression and obesity: evidence of shared biological mechanisms
Milaneschi, Y., Simmons, W. K., van Rossum, E. F. C., & Penninx, B. W. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0017-5 · Cited by 1,073 · cited 1×
“The adipose-derived hormone leptin is well known for its function in controlling energy homeostasis and has been recently involved in regulating mood and emotion [59, 60].”
BDNF and synaptic plasticity, cognitive function, and dysfunction
Lu, B., Nagappan, G., & Lu, Y. (2014) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-45106-5_9 · Cited by 1,043
Vulnerability genes or plasticity genes?
Belsky, J., Jonassaint, C., Pluess, M., Stanton, M., Brummett, B., & Williams, R. (2009) · Molecular Psychiatry · doi:10.1038/mp.2009.44 · Cited by 1,017 · cited 1×
“A number of evidence support a role for serotonin in increasing brain plasticity and enhancing susceptibility to the environment [3, 8, 9].”
The antidepressant fluoxetine restores plasticity in the adult visual cortex
Vetencourt, J. F. M., Sale, A., Viegi, A., Baroncelli, L., De Pasquale, R., F. O'Leary, O., Castrén, E., & Maffei, L. (2008) · Science · doi:10.1126/science.1150516 · Cited by 890
Effects of Chronic Fluoxetine in Animal Models of Anxiety and Depression
Dulawa, S. C., Holick, K. A., Gundersen, B., & Hen, R. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300433 · Cited by 671 · cited 1×
“The solutions were prepared according to the mouse average weight and daily water consumption in order to provide an average daily intake of 30mg/kg of FLX [20] and 200mg/kg of MET, respectively [21, 22].”
A trans-dimensional approach to the behavioral aspects of depression
Bessa, J. M. (2009) · Frontiers in Behavioral Neuroscience · doi:10.3389/neuro.08.001.2009 · Cited by 469 · cited 1×
“However, other studies found that mice treated with SSRI in a stressful environment show an improvement of the depression-like profile [35, 36].”
Leptin: A potential novel antidepressant
Lu, X.-Y., Kim, C. S., Frazer, A., & Zhang, W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508901103 · Cited by 446 · cited 1×
“Low levels of leptin are associated to depression in humans, and preclinical models as well as pharmacological studies indicate leptin as a potential antidepressant drug [61].”
Stress: metaplastic effects in the hippocampus
Kim, J. J., & Yoon, K. S. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01322-8 · Cited by 403
Pathophysiology of depression: the concept of synaptic plasticity
Duman, R. S. (2002) · European Psychiatry · doi:10.1016/s0924-9338(02)00654-5 · Cited by 361 · cited 1×
“Indeed, according to the “neurotrophic hypothesis of depression,” the psychopathology is associated with the reduction of brain BDNF levels and antidepressant treatments alleviate depressive symptoms increasing its levels [6, 67].”
Brain-derived neurotrophic factor in mood disorders and antidepressant treatments
Castrén, E., & Kojima, M. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.07.010 · Cited by 337
Alfarez, D. N., Joëls, M., & Krugers, H. J. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02622.x · Cited by 258
Alboni, S., van Dijk, R. M., Poggini, S., Milior, G., Perrotta, M., Drenth, T., Brunello, N., Wolfer, D. P., Limatola, C., Amrein, I., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2015.142 · Cited by 207 · cited 3×
“In conclusion, previous works by us and others have found that FLX administration has beneficial effects in an enriched environment but has no effects or even leads to detrimental outcome when administered in a stressful environment [4, 5, 90].”
Self-citationAndrus, B. M., Blizinsky, K., Vedell, P. T., Dennis, K., Shukla, P. K., Schaffer, D. J., Radulovic, J., Churchill, G. A., & Redei, E. E. (2012) · Molecular Psychiatry · doi:10.1038/mp.2010.119 · Cited by 178 · cited 1×
“In particular, we focused on IGF2 that is a key molecule in vulnerability to stress and a potential molecular target able to trigger anti-depressant action [39 – 41].”
Branchi, I. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.08.011 · Cited by 156
Self-citationKorz, V., & Frey, J. U. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-19-07281.2003 · Cited by 155 · cited 1×
“In particular, it has been reported that MRs, more expressed in the ventral part [84], facilitate LTP [85, 86], while GRs, more abundant in the dorsal part of the hippocampus [84], impair LTP [87].”
Maras, P. M., Molet, J., Chen, Y., Rice, C., Ji, S. G., Solodkin, A., & Baram, T. Z. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.12 · Cited by 118 · cited 1×
“…LTP magnitude is smaller in the ventral than in the dorsal hippocampus [73 – 75] and is di ff erentially modulated by stress in the two regions [76 – 81], being reduced or not a ff ected in the dorsal but increased in the ventral hippocampus following both acute stress [82, 83] and chronic stress…”
Citalopram counteracts depressive-like symptoms evoked by chronic social stress in rats
Rygula, R., Abumaria, N., Flügge, G., Hiemke, C., Fuchs, E., Rüther, E., & Havemann-Reinecke, U. (2006) · Behavioural Pharmacology · doi:10.1097/01.fbp.0000186631.53851.71 · Cited by 104 · cited 1×
“However, other studies found that mice treated with SSRI in a stressful environment show an improvement of the depression-like profile [35, 36].”
Unique regulation of long term potentiation in the rat ventral hippocampus
Maggio, N., & Segal, M. (2007) · Hippocampus · doi:10.1002/hipo.20237 · Cited by 100
Wiegert, O., Pu, Z., Shor, S., Joëls, M., & Krugers, H. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.05.039 · Cited by 87
Cited by
Zemdegs, J., Martin, H., Pintana, H., Bullich, S., Manta, S., Marqués, M. A., Moro, C., Layé, S., Ducrocq, F., Chattipakorn, N., et al. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.2904-18.2019 · Cited by 151
IGF2 in memory, neurodevelopmental disorders, and neurodegenerative diseases
Alberini, C. M. (2023) · Trends in Neurosciences · doi:10.1016/j.tins.2023.03.007 · Cited by 89
Insulin modulates emotional behavior through a serotonin-dependent mechanism
Martin, H., Bullich, S., Martinat, M., Chataigner, M., Di Miceli, M., Simon, V., Clark, S., Butler, J., Schell, M., Chopra, S., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-022-01812-3 · Cited by 50
El Massry, M., Alaeddine, L. M., Ali, L., Saad, C., & Eid, A. A. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867327666200908114902 · Cited by 27
Cisbani, G., Poggini, S., Laflamme, N., Pons, V., Tremblay, M.-È., Branchi, I., & Rivest, S. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.113039 · Cited by 6
Self-citation
Metadata
- Authors
- Poggini, S., Golia, M. T., Alboni, S., Milior, G., Sciarria, L. P., Viglione, A., Matte Bon, G., Brunello, N., Puglisi-Allegra, S., Limatola, C., Maggi, L., & Branchi, I.
- Venue
- Neural Plasticity
- Publisher
- Wiley
- Published
- 2019-01-21
- Volume
- 2019
- Pages
- 1-12
- ISSN
- 1687-5443 (ISSN-L)
- 2090-5904
- OpenAlex
- W2908827463
- Cited by
- 50
- References
- 24
- FWCI
- 4.05
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.